← Open Payments lookup

COREY MISKEVICS: Open Payments

NPI 1962183160 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$968 in 49 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $1,939 · 2025 $968

Food & beverage: $941Education: $27
CompanyPaymentsAmount
ABBVIE INC.14$170
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$164
E.R. Squibb & Sons, L.L.C.6$124
Takeda Pharmaceuticals U.S.A., Inc.4$91
Otsuka America Pharmaceutical, Inc.4$90
Neurocrine BioSciences, Inc.2$74
Axsome Therapeutics, Inc.2$49
Vanda Pharmaceuticals Inc.3$49
Lundbeck LLC1$28
Janssen Pharmaceuticals, Inc1$26

Products named: VRAYLAR, CAPLYTA, COBENFY, REXULTI, TRINTELLIX, INGREZZA, Auvelity, FANAPT.

Industry payments across NC — which companies pay providers there.